Passa al contenuto

1A03400

USP

Bortezomib L-Phenylalanyl Analog

Pharmaceutical Analytical Impurity (PAI)

Sinonimo/i:

Bortezomib L-Phenylalanyl Analog, (((R)-3-METHYL-1-((S)-3-PHENYL-2-((S)-3-PHENYL-2-(PYRAZINE-2-CARBOXAMIDO)PROPANAMIDO)PROPANAMIDO)BUTYL)BORONIC ACID)

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione

Informazioni su questo articolo

Formula empirica (notazione di Hill):
C28H34BN5O5
Numero CAS:
Peso molecolare:
531.41
MDL number:
NACRES:
NA.24
UNSPSC Code:
41116107
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


grade

pharmaceutical analytical impurity (PAI)

agency

USP

API family

bortezomib

manufacturer/tradename

USP

application(s)

pharmaceutical
pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

General description

Find answers to frequently asked questions on USP products in USP FAQs.
Bortezomib L-Phenylalanyl Analog is a USP Pharmaceutical Analytical Impurity (PAI).


USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.


Associated Drug Substance: Bortezomib


Therapeutic Area: Oncology

Application

Bortezomib L-Phenylalanyl Analog (USP PAI) is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

Other Notes

Sales restrictions may apply.
USP issued SDS can be found here


Pittogrammi

Health hazardExclamation mark

Parola di avvertenza

Warning

Codici di pericolo

Hazard Classifications

Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 2

Organi bersaglio

Gastro-intestinal system

Classe di stoccaggio

11 - Combustible Solids

Che succede?

WGK 3

Punto di infiammabilità (°F)

Not applicable

Punto di infiammabilità (°C)

Not applicable



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti